Dolby (DLB) Form 144 Notifies Sale of 7,000 Restricted Shares

Rhea-AI Filing Summary

Form 144 filed for Dolby Laboratories (DLB): The filer notifies a proposed sale of 7,000 shares of Common Stock through Morgan Stanley Smith Barney on the NYSE with an approximate aggregate market value of $524,440, and an approximate sale date of 08/22/2025. The shares were acquired as restricted stock: 5,670 shares on 05/16/2023 and 1,330 shares on 12/15/2023. The filing reports no securities sold in the past three months by the selling person. The filer also signs the standard representation that they are not aware of any material nonpublic information about the issuer.

Insights

Securities Analyst

TL;DR: Small insider sale filed: 7,000 shares worth $524,440 planned to be sold via Morgan Stanley on NYSE.

This Form 144 notifies a proposed sale of 7,000 common shares, acquired as restricted stock in two tranches during 2023. The disclosed aggregate value is $524,440 against 95,844,185 shares outstanding, indicating a de minimis ownership reduction and limited market impact. The filing includes the standard attestation of no undisclosed material information. No sales in the prior three months were reported.

Corporate Governance Expert

TL;DR: Routine compliance disclosure for planned sale of restricted shares; governance implications are minimal.

The Form 144 appears procedurally complete: broker, sale date, acquisition dates, and nature of acquisition (restricted stock) are provided. Given the small size relative to shares outstanding, this filing represents a routine liquidity event rather than a material governance concern. The seller's attestation about material information is included as required.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7000	524440.00	95844185	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2023	Restricted Stock	Issuer			1330	12/15/2023	Not Applicable
Common	05/16/2023	Restricted Stock	Issuer			5670	05/16/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DLB Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 7,000 common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $524,440 and an approximate sale date of 08/22/2025.

When were the shares to be sold originally acquired according to the filing?

The shares were acquired as restricted stock: 5,670 shares on 05/16/2023 and 1,330 shares on 12/15/2023.

Does the filing report any securities sold in the past three months by the seller?

No. The Form 144 indicates "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale listed in the Form 144?

The broker named in the filing is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.

Does the filer claim to possess undisclosed material information about Dolby (DLB)?

No. By signing the notice the person represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.